Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
JNCI Cancer Spectrum
|
March 15, 2026
Long-Term follow-up of S0221, comparing alternative Dose-Schedules of anthracycline/taxane therapy in early breast cancer
Azka Ali, William E Barlow, Halle C F Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2009
Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial
James C Yao, Catherine Lombard-Bohas, Eric Baudin, et al.
Journal of the National Cancer Institute
|
March 17, 2018
Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study
Gary R Zirpoli, Susan E McCann, Lara E Sucheston-Campbell, et al.
JNCI Cancer Spectrum
|
September 6, 2021
Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo
Pamela J Goodwin, Ryan J O Dowling, Marguerite Ennis, et al.
Breast Cancer Research : BCR
|
November 30, 2018
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
Jennifer M Mongiovi, Gary R Zirpoli, Rikki Cannioto, et al.
Clinical Breast Cancer
|
November 8, 2024
Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience
Nusrat Jahan, Jodi Taraba, Nicholas J Boddicker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 2023
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer
Pamela J Goodwin, Bingshu E Chen, Karen A Gelmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2015
Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)
Nancy U Lin, Hao Guo, Jeffrey T Yap, et al.
JAMA Network Open
|
May 4, 2023
Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer
Rikki A Cannioto, Kristopher M Attwood, Evan W Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2024
Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial
Tufia C Haddad, Vera J Suman, Karthik V Giridhar, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
JNCI Cancer Spectrum
|
March 15, 2026
Long-Term follow-up of S0221, comparing alternative Dose-Schedules of anthracycline/taxane therapy in early breast cancer
Azka Ali, William E Barlow, Halle C F Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2009
Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial
James C Yao, Catherine Lombard-Bohas, Eric Baudin, et al.
Journal of the National Cancer Institute
|
March 17, 2018
Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study
Gary R Zirpoli, Susan E McCann, Lara E Sucheston-Campbell, et al.
JNCI Cancer Spectrum
|
September 6, 2021
Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo
Pamela J Goodwin, Ryan J O Dowling, Marguerite Ennis, et al.
Breast Cancer Research : BCR
|
November 30, 2018
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
Jennifer M Mongiovi, Gary R Zirpoli, Rikki Cannioto, et al.
Clinical Breast Cancer
|
November 8, 2024
Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience
Nusrat Jahan, Jodi Taraba, Nicholas J Boddicker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 2023
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer
Pamela J Goodwin, Bingshu E Chen, Karen A Gelmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2015
Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)
Nancy U Lin, Hao Guo, Jeffrey T Yap, et al.
JAMA Network Open
|
May 4, 2023
Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer
Rikki A Cannioto, Kristopher M Attwood, Evan W Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2024
Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial
Tufia C Haddad, Vera J Suman, Karthik V Giridhar, et al.
Page
of 8